BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 26477687)

  • 1. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.
    Blombery P; Kivivali L; Pepperell D; McQuilten Z; Engelbrecht S; Polizzotto MN; Phillips LE; Wood E; Cohney S;
    Intern Med J; 2016 Jan; 46(1):71-9. PubMed ID: 26477687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.
    Zhou X; Ye X; Ren Y; Mei C; Ma L; Huang J; Xu W; Wei J; Ye L; Mai W; Qian W; Meng H; Jin J; Tong H
    Front Med; 2016 Dec; 10(4):430-436. PubMed ID: 27878664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
    Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
    Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
    Yagi H; Matsumoto M; Fujimura Y
    Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
    Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
    Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
    Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients].
    Deroux A; Sirodot M; Daguindau N; Barro C; Coppo P; Bouillet L
    Rev Med Interne; 2016 Jan; 37(1):13-8. PubMed ID: 26065327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF; Rock G; Barth D; Arnold DM; Webert KE; Yenson PR; Kelton JG; Li L; Foley SR;
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
    Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
    J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).
    Gómez-Seguí I; Francés Aracil E; Mingot-Castellano ME; Vara Pampliega M; Goterris Viciedo R; García Candel F; Pascual Izquierdo C; Del Río Garma J; Guerra Domínguez L; Vicuña Andrés I; Garcia-Arroba Peinado J; Zalba Marcos S; Vidan Estévez JM; González Arias E; Campuzano Saavedra V; García Gala JM; Ortega Sanchez S; Martínez Nieto J; Pardo Gambarte L; Solé Rodríguez M; Fernández-Docampo M; Avila Idrovo LF; Hernández L; Cid J; de la Rubia Comos J;
    Br J Haematol; 2023 Dec; 203(5):860-871. PubMed ID: 37723363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.